Ocular Therapeutix Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	51.95	63.72	58.44	51.49	43.52
Revenue Growth (YoY)	-18.47%	9.03%	13.49%	18.32%	150.08%
Cost of Revenue	203.67	133.26	66.34	58	54.49
Gross Profit	-151.72	-69.54	-7.89	-6.51	-10.97
Selling, General & Admin	118.3	91.34	74.49	72.15	67.07
Operating Expenses	118.3	91.34	74.49	72.15	67.07
Operating Income	-270.02	-160.88	-82.38	-78.65	-78.04
Interest Expense	-11.84	-13.58	-11.34	-7.02	-6.67
Interest & Investment Income	18.36	20.28	3.98	0.8	0.03
Other Non Operating Income (Expenses)	-2.44	-0.48	-5.19	13.84	78.12
EBT Excluding Unusual Items	-265.94	-154.66	-94.93	-71.04	-6.55
Merger & Restructuring Charges	-	-1.6	-	-	-
Other Unusual Items	-	-37.25	14.19	-	-
Pretax Income	-265.94	-193.51	-80.74	-71.04	-6.55
Net Income	-265.94	-193.51	-80.74	-71.04	-6.55
Net Income to Common	-265.94	-193.51	-80.74	-71.04	-6.55
Shares Outstanding (Basic)	187	158	80	77	76
Shares Outstanding (Diluted)	187	158	86	83	82
Shares Change (YoY)	18.31%	84.90%	3.57%	0.59%	35.24%
EPS (Basic)	-1.42	-1.22	-1.01	-0.92	-0.09
EPS (Diluted)	-1.42	-1.22	-1.02	-0.97	-0.98
Free Cash Flow	-216.89	-135.97	-76.32	-63.32	-66.74
Free Cash Flow Per Share	-1.16	-0.86	-0.89	-0.77	-0.81
Gross Margin	-292.04%	-109.13%	-13.51%	-12.64%	-25.20%
Operating Margin	-519.75%	-252.47%	-140.96%	-152.74%	-179.31%
Profit Margin	-511.90%	-303.67%	-138.15%	-137.95%	-15.06%
Free Cash Flow Margin	-417.50%	-213.37%	-130.59%	-122.96%	-153.36%
EBITDA	-265.69	-157.1	-79.4	-76.55	-75.62
EBITDA Margin	-	-246.53%	-135.86%	-148.65%	-173.74%
D&A For EBITDA	4.32	3.79	2.98	2.11	2.42
EBIT	-270.02	-160.88	-82.38	-78.65	-78.04
EBIT Margin	-	-252.47%	-140.96%	-152.74%	-179.31%
Revenue as Reported	51.95	63.72	58.44	51.49	43.52
Advertising Expenses	0.51	0.92	0.88	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.